Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Procter & Gamble Health Ltd., incorporated in the year 1967, is a Mid Cap company (having a market cap of Rs 8,801.66 Crore) operating in Pharmaceuticals sector. Procter & Gamble Health Ltd. key ...